Bayer subsidiary BlueRock Therapeutics has dosed the first Parkinson's disease patient in a phase 1 trial of its cell-based therapy DA01, which aims to replenish the neurons lost in people with the ...

Bayer subsidiary BlueRock Therapeutics is evaluating digital health technologies that it hopes could support the development of its stem cell-based therapy for Parkinson’s disease, currently in ...

This GSM phone is aimed at kids, with its small size, simplified interface, and parental controls. Features include dedicated speed-dial buttons for "mom" and "dad", LCD display with selectable ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

KTOS Kratos Defense & Security Solutions, Inc.